Dual effects of IGFBP‐3 on endothelial cell apoptosis and survival: Involvement of the sphingolipid signaling pathways

Insulin‐like growth factor binding protein (IGFBP)‐3 has both growth‐inhibiting and growth‐promoting effects at the cellular level. The cytotoxic action of several anticancer drugs is linked to increased ceramide generation through sphingomyelin hydrolysis or de novo biosynthesis. Herein, we investigated the role of IGFBP‐3 on apoptosis of human umbilical vein endothelial cells (HUVEC) and its relationship with ceramide levels. We report that IGFBP‐3 exerts dual effects on HUVEC, potentiating doxorubicin‐induced apoptosis but enhancing survival in serum‐starved conditions. Ceramide was increased by IGFBP‐3 in the presence of doxorubicin and decreased when IGFBP‐3 was added alone to cells cultured in serum‐free medium. The protection exerted by the ceramide synthase inhibitor fumonisin B1 over doxorubicin‐induced apoptosis was enhanced by IGFBP‐3 with concomitant reduction of ceramide levels. IGFBP‐3 alone activated sphingosine kinase (SK) and increased SK1 mRNA; the SK inhibitor N,N‐dimethylsphingosine (DMS) blocked IGFBP‐3 antiapoptotic effect. Moreover, IGFBP‐3 increased IGF‐I mRNA and dramatically enhanced IGF‐I release. IGF‐I receptor (IGF‐IR) and its downstream signaling pathways Akt and ERK were phosphorylated by IGFBP‐3, whereas inhibition of IGF‐IR phosphorylation with tyrphostin AG1024 suppressed the antiapopoptic effect of IGFBP‐3. Finally, IGFBP‐3 increased endothelial cell motility in all experimental conditions. These findings provide evidence that IGFBP‐3 differentially regulates endothelial cell apoptosis by involvement of the sphingolipid signaling pathways. Moreover, the survival effect of IGFBP‐3 seems to be mediated by the IGF‐IR.

[1]  A. Giuliano,et al.  Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells Published, JLR Papers in Press, February 16, 2004. DOI 10.1194/jlr.M300486-JLR200 , 2004, Journal of Lipid Research.

[2]  B. Berk,et al.  Sphingosine 1-Phosphate Transactivates the Platelet-Derived Growth Factor β Receptor and Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells , 2004 .

[3]  P. Delafontaine,et al.  Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[4]  S. Zerp,et al.  N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx , 2004, British Journal of Cancer.

[5]  F. Scarlatti,et al.  The FASEB Journal express article 10.1096/fj.03-0292fje. Published online October 16, 2003. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling , 2022 .

[6]  E. Ghigo,et al.  Insulin-like growth factor binding protein-3 mediates serum starvation- and doxorubicin-induced apoptosis in H9c2 cardiac cells , 2003, Journal of endocrinological investigation.

[7]  A. Billich,et al.  Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases* , 2003, Journal of Biological Chemistry.

[8]  F. Tang,et al.  Cellular growth inhibition by IGFBP‐3 and TGF‐β1 requires LRP‐1 , 2003 .

[9]  Adrian L Harris,et al.  Angiogenesis in endocrine tumors. , 2003, Endocrine reviews.

[10]  Carine Michiels,et al.  Endothelial cell functions , 2003, Journal of cellular physiology.

[11]  G. Camussi,et al.  CD40-dependent Activation of Phosphatidylinositol 3-Kinase/Akt Pathway Mediates Endothelial Cell Survival and in Vitro Angiogenesis* , 2003, The Journal of Biological Chemistry.

[12]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[13]  J. Folkman,et al.  Angiogenesis and apoptosis. , 2003, Seminars in cancer biology.

[14]  F. Bussolino,et al.  Insulin‐like growth factor binding protein‐3 is overexpressed in endothelial cells of mouse breast tumor vessels , 2003, International journal of cancer.

[15]  P. Cohen,et al.  Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival. , 2003, The Journal of clinical endocrinology and metabolism.

[16]  M. Thomm,et al.  A Novel Archaeal Transcriptional Regulator of Heat Shock Response* , 2003, The Journal of Biological Chemistry.

[17]  T. Levade,et al.  Sphingomyelin hydrolysis during apoptosis. , 2002, Biochimica et biophysica acta.

[18]  A. Merrill,et al.  Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. , 2002, Biochimica et biophysica acta.

[19]  Y. Hannun,et al.  Ceramide in apoptosis: an overview and current perspectives. , 2002, Biochimica et biophysica acta.

[20]  D. Malan,et al.  Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT , 2002, The Journal of cell biology.

[21]  S. Groshen,et al.  Ceramide Signaling in Fenretinide-induced Endothelial Cell Apoptosis* , 2002, The Journal of Biological Chemistry.

[22]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[23]  Weicheng Wu,et al.  Sphingosine Kinase Mediates Vascular Endothelial Growth Factor-Induced Activation of Ras and Mitogen-Activated Protein Kinases , 2002, Molecular and Cellular Biology.

[24]  C. McCaig,et al.  Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-β) in normal vs cancerous breast epithelial cells , 2002, British Journal of Cancer.

[25]  H. Yi,et al.  Enhanced expression of insulin-like growth factor binding protein-3 sensitizes the growth inhibitory effect of anticancer drugs in gastric cancer cells. , 2002, Biochemical and biophysical research communications.

[26]  J. Ricort,et al.  Insulin-like Growth Factor-binding Protein-3 Activates a Phosphotyrosine Phosphatase , 2002, The Journal of Biological Chemistry.

[27]  G. Velasco,et al.  De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. , 2002, The Biochemical journal.

[28]  J. Redondo,et al.  Doxorubicin Induces Apoptosis and CD95 Gene Expression in Human Primary Endothelial Cells through a p53-dependent Mechanism* , 2002, The Journal of Biological Chemistry.

[29]  J. Wilce,et al.  Role of Interfacial Hydrophobic Residues in the Stabilization of the Leucine Zipper Structures of the Transcription Factors c-Fos and c-Jun* , 2002, The Journal of Biological Chemistry.

[30]  A. Tedgui,et al.  Anti-Inflammatory Mechanisms in the Vascular Wall , 2001, Circulation research.

[31]  ZiadMallat,et al.  Anti-Inflammatory Mechanisms in the Vascular Wall , 2001 .

[32]  T. Billiar,et al.  Sphingosine 1-Phosphate Protects Human Umbilical Vein Endothelial Cells from Serum-deprived Apoptosis by Nitric Oxide Production* , 2001, The Journal of Biological Chemistry.

[33]  S. Yakar,et al.  The somatomedin hypothesis: 2001. , 2001, Endocrine reviews.

[34]  K. L. Pierce,et al.  Transactivation of the EGF Receptor Mediates IGF-1-stimulated Shc Phosphorylation and ERK1/2 Activation in COS-7 Cells* , 2000, The Journal of Biological Chemistry.

[35]  H. Fraser,et al.  Changes in insulin-like growth factor-binding protein-3 messenger ribonucleic acid in endothelial cells of the human corpus luteum: a possible role in luteal development and rescue. , 2000, The Journal of clinical endocrinology and metabolism.

[36]  D. Perry.  The Role of De Novo Ceramide Synthesis in Chemotherapy‐Induced Apoptosis , 2000, Annals of the New York Academy of Sciences.

[37]  J. Rosenbloom,et al.  IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[38]  S. Jain,et al.  Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. , 1999, Experimental cell research.

[39]  K. Yamauchi,et al.  IGF-1 regulates migration and angiogenesis of human endothelial cells. , 1999, Endocrine journal.

[40]  E. Wilson,et al.  Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. , 1999, Endocrinology.

[41]  R. Kolesnick,et al.  Signal transduction of stress via ceramide. , 1998, The Biochemical journal.

[42]  L. Carlsson,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Growth Hormone Treatment Prevents the Decrease in Insulin-Like Growth Factor I Gene Expression in Patients Undergoing Abdominal Surgery* , 2022 .

[43]  P. Newcomb,et al.  Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner* , 1997, The Journal of Biological Chemistry.

[44]  P. Cohen,et al.  Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism* , 1997, The Journal of Biological Chemistry.

[45]  S. Velasco-Miguel,et al.  Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.

[46]  K. Scotto,et al.  Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals , 1995, Cell.

[47]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[48]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[49]  C. Conover,et al.  Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. , 1992, Endocrinology.

[50]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[51]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[52]  B. Berk,et al.  Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. , 2004, Circulation research.

[53]  J. Visser,et al.  Functional cloning of IGFBP-3 from human microvascular endothelial cells reveals its novel role in promoting proliferation of primitive CD34+CD38- hematopoietic cells in vitro. , 2003, Oncology research.

[54]  J. Ricort,et al.  Insulin-like Growth Factor-binding Protein-3 Activates a Phosphotyrosine Phosphatase EFFECTS ON THE INSULIN-LIKE GROWTH FACTOR SIGNALING PATHWAY* , 2002 .

[55]  A. Levitzki,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Specific Inhibition of Insulin-Like Growth Factor-1 and Insulin Receptor Tyrosine Kinase Activity and Biological Function by Tyrphostins , 2022 .